{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T16:11:29Z","timestamp":1794759089403,"version":"4.9.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.neurot.2025.e00728","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T20:06:02Z","timestamp":1756843562000},"page":"e00728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["A double-blind, controlled trial of circadian effective light therapy in patients with Parkinson's disease"],"prefix":"10.1016","volume":"22","author":[{"given":"Bradley T.","family":"Wyman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Hendrix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Groves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Croft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Ellison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Warren","family":"Olanow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Kieburtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neurot.2025.e00728_bib1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/jamaneurol.2013.6239","article-title":"Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease","volume":"71","author":"Videnovic","year":"2014","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00728_bib2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/jamaneurol.2014.65","article-title":"Sleep and circadian rhythm regulation in early Parkinson disease","volume":"71","author":"Breen","year":"2014","journal-title":"JAMA Neurol"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00728_bib3","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1210\/jc.2003-030570","article-title":"High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light","volume":"88","author":"Lockley","year":"2003","journal-title":"J Clin Endocrinol Metabol"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00728_bib4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrn3743","article-title":"Light as a central modulator of circadian rhythms, sleep and affect","volume":"15","author":"LeGates","year":"2014","journal-title":"Nat Rev Neurosci"},{"issue":"16","key":"10.1016\/j.neurot.2025.e00728_bib5","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.1523\/JNEUROSCI.21-16-06405.2001","article-title":"Action spectrum for melatonin regulation in humans: Evidence for a novel circadian photoreceptor","volume":"21","author":"Brainard","year":"2001","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00728_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-26078-0","article-title":"Melanopsin-mediated pupil function is impaired in Parkinson\u2019s disease","volume":"8","author":"Joyce","year":"2018","journal-title":"Scientific Reports"},{"issue":"6944","key":"10.1016\/j.neurot.2025.e00728_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature01761","article-title":"Melanopsin and rod\u2013cone photoreceptive systems account for all major accessory visual functions in mice","volume":"424","author":"Hattar","year":"2003","journal-title":"Nature"},{"issue":"31","key":"10.1016\/j.neurot.2025.e00728_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000741","article-title":"Spectral responses of the human circadian system depend on the irradiance and duration of exposure to light","volume":"2","author":"Gooley","year":"2010","journal-title":"Sci Transl Med"},{"issue":"7191","key":"10.1016\/j.neurot.2025.e00728_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature06829","article-title":"Melanopsin cells are the principal conduits for rod\/cone input to non-image forming vision","volume":"453","author":"G\u00fcler","year":"2008","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00728_bib10","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3233\/JPD-202178","article-title":"Melanopsin cell dysfunction is involved in sleep disruption in Parkinson\u2019s disease","volume":"10","author":"Feigl","year":"2020","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.neurot.2025.e00728_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102474","article-title":"Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson\u2019s disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trial","volume":"69","author":"Feigl","year":"2024","journal-title":"eClinicalMedicine"},{"issue":"Pt 5","key":"10.1016\/j.neurot.2025.e00728_bib12","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awp068","article-title":"The retina in Parkinson\u2019s disease","volume":"132","author":"Archibald","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurot.2025.e00728_bib13","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3389\/fneur.2018.01047","article-title":"Melanopsin retinal ganglion cells and pupil: Clinical implications for neuro-ophthalmology","volume":"9","author":"La Morgia","year":"2018","journal-title":"Front Neurol"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00728_bib14","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.5665\/SLEEP.1242","article-title":"Sleep disturbances are related to decreased transmission of blue light to the retina caused by lens yellowing","volume":"34","author":"Kessel","year":"2011","journal-title":"Sleep"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00728_bib15","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/mds.21542","article-title":"Bright light therapy in Parkinson\u2019s disease: A pilot study","volume":"22","author":"Paus","year":"2007","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00728_bib16","doi-asserted-by":"crossref","first-page":"e1145","DOI":"10.1212\/WNL.0000000000007090","article-title":"Bright light therapy for depression in Parkinson disease: A randomized controlled trial","volume":"92","author":"Rutten","year":"2019","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00728_bib17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jamaneurol.2016.5192","article-title":"Timed light therapy for sleep and daytime sleepiness associated with Parkinson disease a randomized clinical trial","volume":"74","author":"Videnovic","year":"2017","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00728_bib18","doi-asserted-by":"crossref","first-page":"7982","DOI":"10.1038\/s41598-020-64645-6","article-title":"Bright light improves sleep in patients with Parkinson\u2019s disease: possible role of circadian restoration","volume":"10","author":"Endo","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00728_bib19","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mds.27602","article-title":"Update on treatments for nonmotor symptoms of Parkinson\u2019s disease\u2014an evidence-based medicine review","volume":"34","author":"Seppi","year":"2019","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00728_bib20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/CM9.0000000000001732","article-title":"Therapeutic potential of bright light therapy for the non-motor symptoms in Parkinson\u2019s disease","volume":"135","author":"Shen","year":"2022","journal-title":"Chin Med J"},{"key":"10.1016\/j.neurot.2025.e00728_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.107149","article-title":"Supplemental ambient lighting intervention to improve sleep in Parkinson\u2019s disease: A pilot trial","volume":"129","author":"Yoo","year":"2024","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00728_bib22","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3390\/brainsci14121218","article-title":"Circadian intervention improves Parkinson\u2019s disease and may slow disease progression: a ten year retrospective study","volume":"14","author":"Willis","year":"2024","journal-title":"Brain Sci"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00728_bib23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/07420520701420717","article-title":"Primary and secondary features of Parkinson\u2019s disease improve with strategic exposure to bright light: a case study","volume":"24","author":"Willis","year":"2007","journal-title":"Chronobiol Int"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00728_bib24","doi-asserted-by":"crossref","DOI":"10.1515\/revneuro-2011-0072","article-title":"A historical justification for and retrospective analysis of the systematic application of light therapy in Parkinson\u2019s disease","volume":"23","author":"Willis","year":"2012","journal-title":"Rev Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00728_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF02251135","article-title":"Circadian secretion pattern of melatonin in Parkinson\u2019s disease","volume":"3","author":"Fertl","year":"1991","journal-title":"J Neural Transm Gen Sect"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00728_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00002826-200303000-00005","article-title":"Study of circadian melatonin secretion pattern at different stages of Parkinson\u2019s disease","volume":"26","author":"Bordet","year":"2003","journal-title":"Clin Neuropharmacol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00728_bib27","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/mds.27303","article-title":"Are the MDS-UPDRS\u2013based composite scores clinically applicable?","volume":"33","author":"Makkos","year":"2018","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00728_bib28","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3233\/JPD-230446","article-title":"Modeling of Parkinson\u2019s disease progression and implications for detection of disease modification in treatment trials","volume":"14","author":"Ribba","year":"2024","journal-title":"J Parkinson Dis"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00728_bib29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/ageing\/30.4.299","article-title":"Determining minimally important differences for the PDQ-39 Parkinson\u2019s disease questionnaire","volume":"30","author":"Peto","year":"2001","journal-title":"Age Ageing"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00728_bib30","first-page":"63","article-title":"Light therapy of patients with parkinsonism","volume":"96","author":"Artemenko","year":"1996","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"10.1016\/j.neurot.2025.e00728_bib31","doi-asserted-by":"crossref","DOI":"10.1007\/s13760-019-01214-3","article-title":"Bright light therapy with a head-mounted device for anxiety, depression, sleepiness and fatigue in patients with Parkinson\u2019s disease","author":"Raymackers","year":"2019","journal-title":"Acta neurologica Belgica"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00728_bib32","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/mds.26865","article-title":"Alterations of the circadian system in Parkinson\u2019s disease patients: circadian alterations in Parkinson\u2019s disease","volume":"32","author":"Fifel","year":"2017","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurot.2025.e00728_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.nbscr.2016.11.001","article-title":"Circadian dysregulation in Parkinson\u2019s disease","volume":"2","author":"Videnovic","year":"2017","journal-title":"Neurobiol Sleep Circad Rhy"},{"issue":"S275","key":"10.1016\/j.neurot.2025.e00728_bib34","doi-asserted-by":"crossref","first-page":"j.1755","DOI":"10.1111\/j.1755-3768.2022.15578","article-title":"Inner retina and melanopsin retinal ganglion cells in Parkinson\u2019s disease","volume":"100","author":"La Morgia","year":"2022","journal-title":"Acta Ophthalmologica"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00728_bib35","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40478-018-0596-z","article-title":"Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson\u2019s disease","volume":"6","author":"Ortu\u00f1o-Lizar\u00e1n","year":"2018","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00728_bib36","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/ana.25897","article-title":"Dopaminergic retinal cell loss and visual dysfunction in Parkinson disease","volume":"88","author":"Ortu\u00f1o-Lizar\u00e1n","year":"2020","journal-title":"Ann Neurol"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00728_bib37","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1001\/jamaneurol.2018.0640","article-title":"A histologic study of the circadian system in Parkinson disease, multiple system atrophy, and progressive supranuclear palsy","volume":"75","author":"De Pablo-Fern\u00e1ndez","year":"2018","journal-title":"JAMA Neurol"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00728_bib38","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1017\/S1092852900019611","article-title":"Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects","volume":"10","author":"Terman","year":"2005","journal-title":"CNS spectr"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00728_bib39","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1210\/jc.2004-0957","article-title":"High sensitivity of human melatonin, alertness, thermoregulation, and heart rate to short wavelength light","volume":"90","author":"Cajochen","year":"2005","journal-title":"J Clin Endocrinolo Metabol"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00728_bib40","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.parkreldis.2013.03.003","article-title":"Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson\u2019s disease - A randomized study","volume":"19","author":"Rios Romenets","year":"2013","journal-title":"Parkins Relat Disord"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925002065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925002065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:36:05Z","timestamp":1763638565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747925002065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1878747925002065"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00728","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A double-blind, controlled trial of circadian effective light therapy in patients with Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00728","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00728"}}